1. Home
  2. FPS vs PRAX Comparison

FPS vs PRAX Comparison

Compare FPS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FPS

Forgent Power Solutions Inc. Class A Common Stock

N/A

Current Price

$59.44

Market Cap

7.9B

Sector

Energy

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$263.71

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPS
PRAX
Founded
2023
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FPS
PRAX
Price
$59.44
$263.71
Analyst Decision
Buy
Strong Buy
Analyst Count
8
15
Target Price
$42.63
$572.13
AVG Volume (30 Days)
7.0M
427.5K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$74.33
N/A
Revenue Next Year
$43.11
$7,758.26
P/E Ratio
$526.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.27
$37.25
52 Week High
$65.56
$366.52

Technical Indicators

Market Signals
Indicator
FPS
PRAX
Relative Strength Index (RSI) 62.35 39.24
Support Level $28.96 $157.29
Resistance Level $65.56 $342.62
Average True Range (ATR) 4.68 21.68
MACD -0.12 -6.71
Stochastic Oscillator 70.69 20.77

Price Performance

Historical Comparison
FPS
PRAX

About FPS Forgent Power Solutions Inc. Class A Common Stock

Forgent Power Solutions Inc designs and manufactures electrical distribution equipment for data centers, the power grid, and industrial facilities. Its offerings include automatic transfer switches, transformers (dry type and liquid filled), electrical houses, generator connection cabinets, panelboards, switchboards, switchgear, power distribution units, power skids, remote power panels, and tap boxes.It specializes in manufacturing Custom Products and Powertrain Solutions for technically demanding applications, including data center power distribution, utility substations and energy-intensive manufacturing. The majority of the company's revenue is derived from custom products designed for specific projects with significant engineering consultation.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: